Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel tachykinin antagonists developed by Fujisawa

Feb. 24, 2005

Two novel series of PDE7 inhibitors imparted by Daiichi Suntory

Feb. 24, 2005

CVT-5440: a selective, high affinity adenosine A2B receptor antagonist for asthma therapy

Feb. 24, 2005

PTC Therapeutics receives award to support development of PTC-124

Feb. 24, 2005

Glenmark presents novel PDE4 inhibitors for inflammatory and allergic conditions

Feb. 23, 2005

Prostaglandin D2 (DP) receptor antagonists disclosed by Merck Frosst

Feb. 23, 2005

Approvable letter for Surfaxin

Feb. 23, 2005

NLA Nasal Spray shows rapid relief after histamine challenge

Feb. 23, 2005

First phase I safety study for ASM-8 for asthma

Feb. 22, 2005

Inhibition of IL-6 signaling might be a new approach for allergic asthma treatment

Feb. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...